生物技术初创公司Baseimmune日前宣布完成A轮融资,筹集资金1130万美元,用于推进其机器学习疫苗设计平台的开发。本轮融资由多家知名风投参与,并获得超额认购。
Baseimmune总部位于伦敦,专注利用AI技术简化疫苗的设计和开发流程。此轮融资将用于进一步完善其核心技术和产品线。随着新冠疫情的持续,各类疫苗的研发备受关注,Baseimmune有望在疫苗开发领域占据先机。
投资方面,本轮融资吸引了多家顶级投资机构的积极参与,包括MSD全球健康创新基金、IQ Capital在内的知名风险投资公司。这充分体现了投资方对Baseimmune技术和发展前景的高度认可与信心。
Title: AI vaccine startup Baseimmune receives oversubscribed financing
Keywords: AI vaccine, startup, financing
News content:
Bio-tech startup Baseimmune has recently announced the completion of a Series A financing round, raising $11.3 million to advance the development of its machine learning vaccine design platform. The financing round attracted participation from several top-tier VCs and was oversubscribed.
Headquartered in London, Baseimmune focuses on streamlining vaccine design and development processes using AI technology. The new capital will be used to further enhance its core technology and product pipeline. With the ongoing COVID-19 pandemic, vaccine development is under the spotlight, and Baseimmune is poised to take the lead in this area with its innovative technology.
On the investor side, this round welcomed proactive participation from several leading investment firms, including MSD Global Health Innovation Fund and IQ Capital. It is a strong testament to investors’ recognition of and confidence in Baseimmune’s technology and growth prospects.
【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/
Views: 2